Interaction of a tyrosine kinase type receptor and its ligand induces receptor-dimerization or -oligomerization followed by transphosphorylation and activation of its intrinsic kinase, which leads to a series of intracellular signals. We have previously reported that the membrane-bound form of Steel factor (SLF) induces more persistent tyrosine kinase activation and longer life span of c-kit encoded protein (KIT) than its soluble form (Miyazawa et al, B/ood85:641,1995). In this study, we used YB5.B8 monoclonal antibody (MoAb) that recognizes the extracellular domain of KIT to investigate whether immobilized anti-KIT MoAb can substitute for SLF as a potent activator of KIT by cross-linking receptors and further compared its effect with each SLF isoform in a factordependent cell line M07e. YB5.B8 MoAb in a soluble state suppressed SLF-induced M07e cell proliferation in a dosedependent manner. By contrast, once this antibody was immobilized on the goat-antimouse MoAb (GAM)-coated culture plates, it supported the growth of M07e cells in the absence of any growth factors, whereas culture the cells in GAM alone or YB5.B8 without GAM-coated plates resulted in rapid cell-death within 24 hours. As with the natural ligand SLF, immobilized YB5.B8 MoAb synergized with granulo-EMATOPOIETIC cell growth, differentiation, migration, and apoptosis are regulated by various hematopoietic cytokines. The c-kit proto-oncogene encodes a 145-kD tyrosine kinase type I11 receptor that is a member of the platelet-derived growth factor (PDGF) receptor family with common structural features, including five Ig-like motifs in the extracellular domain, a cytoplasmic domain including a juxta-membrane segment, a kinase domain divided into two subdomains by a kinase insert sequence, and a carboxyterminal segment. Its ligand, Steel factor (SLF) encoded by S1 gene has been cloned and shown to be expressed by bone marrow stromal cells. SLF is a potent costimulatory cytokine that synergizes with a number of cytokines to stimulate growth of hematopoietic progenitors in vitro and blood cell production in vivo in animals (reviewed in Broxmeyer et all). Interaction of a tyrosine kinase type receptor with its ligand ubiquitously induces receptor dimerization or oligomerization followed by activation of intrinsic tyrosine kinase and receptor transphosphorylation. This results in a series of intracellular signals in cell response to the cytokine stimulation.* Many lines of evidence support the idea that the receptor dimerization or oligomerization is an essential step for receptor a~tivation.~ For example, in the CSF-l receptor, mutation or truncation of the carboxyl terminus and specific amino acid substitution in near the fourth Ig-like loop in the extracellular domain induces constitutive receptor dimerization and activation without ligand stimulation, which plays a causal role in tum~rigenesis.~ Recently, the fourth Ig domain of KIT has been defined as the site responsible for receptor dimerization, and deletion of this domain abolished ligand-induced dimerization and completely inhibited signal transd~ction.~ By contrast, in an immunologic field, interaction of T cells with immobilized anti-CD3 andor anti-CD28 antibodies on a solid phase such as Sepharose beads has been used for activation of T cells in vitro, which appears to be caused by clustering of T-cell receptor complex a n d or CD28 molecule^.^^' It has also been reported by others that tyrosine kinase of an EPH-related receptor was activated somewhat during the process of immunoprecipitation using anti-EPH-related receptor antibody conjugated with beads, which was attributed to antibody-mediated clustering and activation of receptors in vitro.' These previous observations raised the question of whether we can activate hematopoietic growth factor receptors by using antibodies to cross-link the extracellular epitopes of the receptors and to mimic the biologic effects of natural ligands.
Interaction of a tyrosine kinase type receptor and its ligand induces receptor-dimerization or -oligomerization followed by transphosphorylation and activation of its intrinsic kinase, which leads to a series of intracellular signals. We have previously reported that the membrane-bound form of Steel factor (SLF) induces more persistent tyrosine kinase activation and longer life span of c-kit encoded protein (KIT) than its soluble form (Miyazawa et al, B/ood85:641,1995) . In this study, we used YB5.B8 monoclonal antibody (MoAb) that recognizes the extracellular domain of KIT to investigate whether immobilized anti-KIT MoAb can substitute for SLF as a potent activator of KIT by cross-linking receptors and further compared its effect with each SLF isoform in a factordependent cell line M07e. YB5.B8 MoAb in a soluble state suppressed SLF-induced M07e cell proliferation in a dosedependent manner. By contrast, once this antibody was immobilized on the goat-antimouse MoAb (GAM)-coated culture plates, it supported the growth of M07e cells in the absence of any growth factors, whereas culture the cells in GAM alone or YB5.B8 without GAM-coated plates resulted in rapid cell-death within 24 hours. As with the natural ligand SLF, immobilized YB5.B8 MoAb synergized with granulo-EMATOPOIETIC cell growth, differentiation, migration, and apoptosis are regulated by various hematopoietic cytokines. The c-kit proto-oncogene encodes a 145-kD tyrosine kinase type I11 receptor that is a member of the platelet-derived growth factor (PDGF) receptor family with common structural features, including five Ig-like motifs in the extracellular domain, a cytoplasmic domain including a juxta-membrane segment, a kinase domain divided into two subdomains by a kinase insert sequence, and a carboxyterminal segment. Its ligand, Steel factor (SLF) encoded by S1 gene has been cloned and shown to be expressed by bone marrow stromal cells. SLF is a potent costimulatory cytokine that synergizes with a number of cytokines to stimulate growth of hematopoietic progenitors in vitro and blood cell production in vivo in animals (reviewed in Broxmeyer et all). Interaction of a tyrosine kinase type receptor with its ligand ubiquitously induces receptor dimerization or oligomerization followed by activation of intrinsic tyrosine kinase and receptor transphosphorylation. This results in a series of intracellular signals in cell response to the cytokine stimulation.* Many lines of evidence support the idea that the receptor dimerization or oligomerization is an essential step for receptor a~tivation.~ For example, in the CSF-l receptor, mutation or truncation of the carboxyl terminus and specific amino acid substitution in near the fourth Ig-like loop in the extracellular domain induces constitutive receptor dimerization and activation without ligand stimulation, which plays a causal role in tum~rigenesis.~ Recently, the fourth Ig domain of KIT has been defined as the site responsible for receptor dimerization, and deletion of this domain abolished ligand-induced dimerization and completely inhibited signal transd~ction.~ By contrast, in an immunologic field, interaction of T cells with immobilized anti-CD3 andor anti-CD28 cyte-macrophage colony-stimulating factor (GM-CSF) in inducing cell proliferation compared with either YB5.B8 MoAb or GM-CSF alone. lmmunoblotting with antiphosphotyrosine MoAb showed that interaction of M07e cells with immobilized YB5.B8 induced tyrosine phosphorylation of a series of intracellular proteins including KIT (145 kD). In addition, cross-linking studies using a water-soluble crosslinking reagent bis-sulfosuccinimidyl-suberate showed that immobilized YB5.B8 MoAb induced dimerization and activation of KIT. However, as with stimulation by the membranebound form of SLF, the kinetics of KIT activation with YB5.B8
MoAb was more prolonged compared with the cells treated with recombinant soluble SLF. Flow cytometry showed that, unlike the cells treated with soluble SLF, no downmodulation of cell-surface KIT expression was observed in M07e cells cultured with immobilized YB5.B8 MoAb. These data suggest that immobilized antibodies against hematopoietic receptors may replace their ligand-stimulators; however, their activities may resemble the membrane-bound form rather than the soluble form of natural ligands. antibodies on a solid phase such as Sepharose beads has been used for activation of T cells in vitro, which appears to be caused by clustering of T-cell receptor complex a n d or CD28 molecule^.^^' It has also been reported by others that tyrosine kinase of an EPH-related receptor was activated somewhat during the process of immunoprecipitation using anti-EPH-related receptor antibody conjugated with beads, which was attributed to antibody-mediated clustering and activation of receptors in vitro.' These previous observations raised the question of whether we can activate hematopoietic growth factor receptors by using antibodies to cross-link the extracellular epitopes of the receptors and to mimic the biologic effects of natural ligands.
In this study, we have attempted to induce dimerization of SLF receptor using immobilized anti-KIT monoclonal antibody (MoAb), YB5.B8,9.'0 and investigated whether it can substitute for ligand stimulation. Additionally, because alternative splicing of exon 6 of the SI gene results in production of two isoforms of Steel factor, ie, membrane bound and soluble (secreted) forms,"." and we have previously reported that the membrane-bound form of SLF induces more persistent activation and longer life span of KIT than its soluble form.'' We further compared the kinetics of KIT activation induced by immobilized anti-KIT antibody and that induced by the membrane-bound or soluble isoforms of SLF stimulation.
MATERIALS AND METHODS
Cytokines, antibodies, and reagents. Highly purified recombinant human (rhu) SLFI4 and rhu granulocyte-macrophage colony stimulating factor (GM-CSF; 4 X IO7 UlmL) were obtained from Dr Douglas E. Williams (Immunex Corp, Seattle, WA). Mouse anti-KIT MoAb, YB5.B8, which recognizes the extracellular epitope of human c-kit-encoded protein was produced as previously described."" Rabbit anti-KIT polyclonal antibody raised against the peptide GSTASSSQPLLVHDDV, a sequence found at the C-termnus, was purchased from Oncogene Science (Uniondale, NY). Mouse antiphosphotyrosine MoAb, 4G10, was obtained from Upstate Biotechnology Inc (Lake Placid, NY). A water-soluble crosslinking reagent, bis-sulfosuccinimidyl-suberate (BS') was purchased from Pierce (Rockford, IL).
M07e cells. The human growth factor-dependent cell line, M07e, was a gift from Aggie Ciarletta (Genetic Institute, Boston, MA). This cell line responds to human GM-CSF and IL-3 and human or murine SLF. The biologic characteristics of this cell line and culture conditions have been previously described." The cells were cultured in RPMI-I 640 medium supplemented with 20% fetal bovine serum (FBS) and 100 U/mL rhuGM-CSF. Exponentially growing M07e cells were washed and then incubated for 18 hours at 37°C in serum-free RPMI-1640 medium containing 0.5% bovine serum albumin (BSA; Sigma, St Louis, MO). After factor-deprivation, cells were washed once with serum-free medium and then used for further experiments.
Immobilization ofYB5.BS MoAb on cultureplates. Affinity-purified goat antimouse Ig (GAM) MoAb (Zymed Laboratories, Inc. San Francisco, CA) was diluted in 50 mmol/L carbonate-bicarbonate buffer (pH 9.6) and aliquotted into each 96-well or 24-well flatbottom plate (Costar, Cambridge, MA) at I O 0 @g/mL. Plates were incubated overnight at 4°C and then extensively washed with phosphate-buffered saline (PBS; pH 7.4). Thereafter, YB5.B8 MoAb at various concentrations in RPM11640 with 10% FBS was added into each well and incubated for 60 minutes at room temperature before the addition of the factor-starved M07e cells (2.5 X IO4 cellslwell). After incubation under various conditions, M07e cells were harvested and lysed with lysis buffer containing Tris-HCI, pH 7.4, I SO mmoVL NaCI, 10% glycerol, I% NP-40, 1 mmol/L phenylmethylsulfonyl fluoride, 0.15 U/mL aprotinin, 10 mmol/L EDTA, I O pg/ mL leupeptin, 100 mmol/L sodium fluoride, 2 mmol/L sodium orthovanadate at 4°C for 30 minutes. Cell lysates were clarified by centrifuging for 30 minutes at 10,OOOg at 4°C. Total protein content of the lysate was determined by a Bio-Rad protein assay kit (Bio-Rad, Richmond, CA). Cell lysates were used for immunoprecipitation and immunoblotting.
Immunoprecipitation and imrnunoblotting. Immunoprecipitation and immunoblotting were performed as previously described." Briefly, cell lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and proteins were electrophoretically transferred onto Immobilon-P membranes (Millipore, Bedford, MA). After blocking residual binding sites on the transfer membrane by incubation with TBST (50 mmol/L Tris-HCL, pH 7.4, 150 mmol/L NaCI, 0.05% Tween-20) containing 1% BSA for 2 hours, the blots were incubated with the appropriate primary antibody for 2 to 4 hours at room temperature. Immunoreactive proteins were visualized colorimetrically. Immunoprecipitations were performed by incubating the cell lysates with anti-KIT antibody for 3 hours at 4°C. Protein A-Sepharose beads (Pierce) were used to collect the antigen-antibody complexes.
Quantitative DNA fragmentation ussays.
['HJ-thymidine-based DNA fragmentation assays were performed as previously described with
Exponentially growing M07e cells in RPMI-1640 supplemented with 20% FBS and 100 U/mL rhuGM-CSF were incubated with ['HI-thymidine (1 kCi/mL) overnight. After extensive washing, ['H]-labeled M07e cells were further cultured in RPMJ-1640 containing 0.5% BSA for 18 hours for factor starvation. Thereafter, the cells (5 X 1OS/well) were inoculated into 96-well flat-bottom multiplate coated with YB5.B8 MoAb and cultured in RPMI-I640 containing 5% FBS for 12 hours in the presence or absence of rhu GM-CSF (50 U/mL). Triton X-l00 was added into each well at final concentration of I % (vol/vol) and incubated for 30 minutes at room temperature. The plate was then centrifuged for I O minutes at 2501: using Tomy TS-4 swing rotor (Tomy, Tokyo, Japan) to separate fragmented DNA from large genomic DNA. The radioactivity associated with fragmented [3H]-labeled DNA released into the supernatants was measured by liquid scintillation counting. Experiments were performed in triplicate.
['HI-thymidine incorporation. After incubation of 1 X I O J M07e cells in MoAb-coated microtiter plates for various periods at 37°C. 0.5 pCi of [%-thymidine (specific activity, 2 Ci/mL; Amersham Corp, Buckinghamshire, UK) was added for a 4-hour pulse at 37°C. The cells were harvested onto filter paper and immersed in Ready Protein scintillation fluid (Beckman Instruments, Fullerton, CA) and incorporated radioactivity (cpm) was determined. Experiments were performed in triplicate Flow c,ytometric anulysis. After culture under various conditions, M07e cells were collected and washed twice with PBS containing 5% FBS. Cells ( I X IO5) suspended in 0.5 mL PBS containing 5% FBS were incubated with YB5.B8 MoAb 
RESULTS
Ambivalent nature of YB5.BS MoAb in M07e cellproliferation. Factor-dependent M07e cells were first cultured with various concentrations of soluble YBS.B8 MoAb, which is directed against extracellular epitope of KIT, in the presence of 10 ng1mL SLF for 72 hours; thereafter, ['HIthymidine was pulsed for 4 hours. As shown in Fig I , YBS.B8 MoAb at the concentrations greater than 500 ngl mL suppressed SLF-induced M07e cell proliferation in a dose-dependent manner. However, once this antibody was immobilized via GAM-coated culture plates, it stimulated the proliferation of M07e cells somewhat in the absence of any growth factors, including SLF (Fig 2) most of M07e cells cultured in YBS.B8 MoAb-coated plates for I2 hours became adherent and some of them changed to a spindle or tear-dropped shape. By contrast, when the cells were cultured without YBS.B8 MoAb, more than 80% of the cells became not viable within 12 hours of incubation. Not shown is that trypan blue dye exclusion tests also showed that less than 15% of M07e cells were viable after 24 hours of culture with either YBS.B8 MoAb or GAM, whereas in the presence of immobilized YBS.B8 MoAb more than 80% of the cells were viable. Because SLF has been known to synergize with various cytokines, including GM-CSF, in hematopoietic cell growth,'.'' we next investigated whether immobilized YBS.B8 MoAb can reproduce synergistic effects of SLF in this system. Proliferation of M07e cells cultured with immobilized YBS.B8 MoAb plus GM-CSF was synergistically enhanced as compared with that of the cells cultured with YB5.B8 MoAb or GM-CSF alone (Fig 4) . This enhancing effect by immobilized YBS.B8 MoAb was almost equivalent to that by 2 ng/mL SLF. 24 hours. Thereafter, we added SO U/mL GM-CSF in these cultures and further incubated the cells for 72 hours at 37°C. At the concentrations more than 1 ,ug/mL of immobilized YBS.B8 MoAb, the conditions that stimulated the growth of M07e cells somewhat (Fig 2) , ['HI-thymidine incorporation was dramatically increased due to additional growth stimulation by GM-CSF, whereas in the cells pretreated either without YB5.B8 MoAb or with a lower concentration of YB5.B8 MoAb, M07e cells did not show an enhanced response to GM-CSF. Consistent with the results of trypan blue dye exclusion tests, these data showed that immobilized YBS.B8 MoAb at optimal condition supports the survival of M07e cells, enabling them to respond to later additional growth stimulation of GM-CSF (Fig S) . In addition, quantitative DNA fragmentation assays showed that, after 12 hours of interaction with immobilized YB5.B8 MoAb, radioactivity of fragmented DNA was significantly suppressed compared with those of the cells cultured with GAM or YB5.B8 MoAb alone (Fig 6) . There was no difference in the amounts of fragmented DNA among the cells cultured in either immobilized YB5.B8 MoAb, GM-CSF, or SLF alone, and the cells cultured with both immobilized MoAb plus GM-CSF or SLF plus GM-CSF. with either GAM or YBS.B8 MoAb alone did not show any change of cellular protein phosphorylation compared with the cells treated with control medium (Fig 7) . Next, we performed a cross-linking study using a water-soluble crosslinking reagent BS.' After 60 minutes of interaction of ["SImethionine-labeled M07e cells with immobilized YBS.B8 MoAb, a cross-linker BS' was added in the culture plates. As shown in Fig 8, the dimerized KIT was detected as a 300-kD band in the cells incubated with immobilized YBS.B8, whereas the cells cultured with either GAM or YBS.B8 MoAb alone showed only the monomeric form of 145-kD KIT. In addition, immunoblotting the same membrane with antiphosphotyrosine MoAb showed that only when the cells were interacted with immobilized YBS.B8 MoAb, dimeric and monomeric forms of KIT were tyrosine phosphorylated (Fig 8) , just as well as ligand-induced transphosphorylation and activation of KIT.*'.'' These data showed that KIT is able to form the dimer and to be activated by interaction 2239 with immobilized anti-KIT antibody, but not by the antibody in soluble form.
Kinetics qf KIT activation b.v immobilized YB5.R8 is similar with the membrane-bound Steel factor rather than its soluble form. Our previous report has shown that the membrane-bound SLF induces more persistent tyrosine kinase activation and longer life span of KIT than its soluble form in M07e cells." Additionally, using the same cell line, we have reported that stimulation with soluble rhuSLF at 37°C induced polyubiquitination of KIT and subsequent internalization of the ligand-receptor complex, leading to rapid proteolysis of KIT protein.'" However, in the case of the membrane-bound SLF stimulation, because the membrane-bound SLF could not be internalized, no downmodulation of cell surface KIT expression occurred and the life span of KIT was much longer, which resulted in more persistent activation of KIT as compared with that by soluble SLF. In this respect, the KIT activation with immobilized anti-KIT antibody could be similar to that by the membrane-bound SLF stimulation. To test this hypothesis, we investigated the kinetics of KIT activation after interaction with immobilized YBS.B8 MoAb. As shown in Fig 9, interaction with soluble rhuSLF induced transient KIT activation; it was activated within S minutes and declined toward baseline within 60 to I20 minutes. On the other hand, it took about 60 minutes to achieve full activation of KIT by immobilized YBS.B8 MoAb. Notably, once KIT was activated, the active state of KIT continued for longer than S hours.
Next, we examined cell-surface KIT expression in M07e by flow cytometry after interaction with immobilized YBS.B8 MoAb (Fig 10) . Treatment with soluble rhuSLF for 60 minutes resulted in downmodulation of cell-surface KIT expression. However, no downmodulation of KIT was detected after interaction with YBS.B8 MoAb for 60 minutes and addition of soluble SLF into this culture resulted in enhanced downmodulation of KIT expression. These results were also consistent with the KIT expression in M07e cells treated with the membrane-bound form of SLF, as previously reported by us.'3
DISCUSSION
Dimerization or oligomerization of receptors is now known to be an essential step for receptor activation (reviewed in Heldin'). In this report, we have shown that immobilized anti-KIT antibody can induce SLF receptor dimerization and activation, leading to biologic effects of SLF in the absence of the cognate ligand. This suggests that immobilized anti-KIT antibody can substitute for SLF stimulation. These effects were only inducible when the antibody was immobilized on the culture plates in our system. In contrast, YBS.B8 MoAb in soluble form suppressed SLF-induced cell proliferation of M07e cells in a dose-dependent manner. Therefore, the soluble form of antibody against extracellular domain of a receptor appears to compete or block the ligand binding site on SLF receptors; however, once YBS.B8 MoAb is immobilized on the culture plates, it can cross-link the extracellular domains of KIT, leading to formation of the receptor dimer or oligomer independent of ligand. In this way, immobilized antireceptor antibody appears to play a role of "a specific cross-linker for receptors" as well as a dent M07e cells, it stimulated the cell proliferation somenatural bivalent ligand. what (Fig 2) . supported the survival (Figs 3 and S) , and also SLF. First, the growth-stimulatory effect by immobilized provides two binding sites for anti-KIT antibodies, the YBS.B8 MoAb even at the optimal condition was relatively YBS.B8 MoAb molecule attached via GAM to the culture weak compared with that by rhuSLF (Figs 1 and 2 ). Consisplate could become denser. This may also lead to an intent with this, the tyrosine phosphorylation level of cellular creased chance of receptor-clustering per cell. (3) Immobiliproteins by immobilized antibody at the optimal condition zation of the Fc portion of anti-KIT antibody on solid phase was lower than that induced by 20 ng/mL rhuSLF (Fig 7) . may work as the fulcrum for making receptor dimerize effiSecond, as shown in Fig 9 , it took about 60 minutes to ciently. These ideas are also supported by the previous studachieve full activation of KIT kinase by immobilized antiies showing that anti-CD3 IgM, which is a pentamer of Ig KIT antibody, whereas soluble rhuSLF promptly induces molecules, is superior to anti-CD3 IgG in T-cell activation tyrosine phosphorylation of cellular proteins within a few in vitro. ' minutes." These observations may be due to the difference KIT was then assessed as described above. This is a reproducible result from three separate experiments. M07e cells was 1.10 X IO"" mol& whereas that of antibody-antigen interaction is known to be around IO" to mol/L." In addition, KIT on M07e cells might be dimerized and activated on the attachment site against the plastic culture dish; therefore, only some part of KIT expressed on M07e cells could be activated by this method. Furthermore, it may take longer time for M07e cells to make a direct contact with antibody coated on plastic culture dish. Further experiments to determine the optimal conditions for activation of KIT using antibody will be required to determine whether it can approach the effectiveness of the natural ligand.
Alternative splicing of exon 6 results in the production of two isoforms of SLF, ie, the membrane-bound and soluble form, respectively."." Several lines of evidence support the physiologic difference between the membrane-bound and soluble forms of SLF. A study of mast cell attachment to fibroblasts derived from SI/SI mice showed that the extracellular domain of the membrane-bound SLF was required to mediate this atta~hment.'~ Adhesion of human megakaryocytes to bone marrow stromal fibroblasts has been shown to be mediated in part by the interaction between membranebound SLF and KIT." In addition, the membrane-bound SLF supports hematopoiesis in a long-term culture system longer than the secreted protein. 26 Using stable gene-transfected stromal cell lines that selectively produce either the membrane-bound or the soluble form of SLF, we have previously reported that the membrane-bound SLF induces more persistent tyrosine kinase activation and longer life span of KIT than its soluble form." As shown in Fig 9, activation of KIT by YB5.B8 MoAb takes a longer time than that by natural ligand. However, it was of interest that, once KIT was activated, the active state of KIT persisted much longer than that induced by soluble SLF stimulation. It has been reported that soluble SLF stimulation induces transient tyrosine kinase activation of KIT and that the tyrosine phosphorylation state of cellular protein returns to unstimulated state within 60 minutes." We have also reported that ligand-KIT com-
Log Fluorescence Intensity
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From plex is rapidly polyubiquitinated, internalized, and degraded. 22 In contrast, when the cells were stimulated with the membrane-bound form of SLF, internalization followed by degradation of KIT could not occur, which may account for the persistent activation of KIT kinase and longer life span of KIT. Therefore, it is easily predictable that the same phenomenon could be occurring in KIT after interaction with immobilized YB5.B8 MoAb. In addition, the data from flow cytometric analysis supports this hypothesis, showing that, as with the membrane-bound SLF stimulation," no rapid downmodulation of cell surface KIT expression occurred after interaction with the immobilized YB5.B8 MoAb (Fig  10) . Taking these lines of evidence together, the quality of signals induced by immobilized YB5.B8 MoAb appears to be similar to the membrane-bound form of SLF rather than the soluble form By our method shown here, another immobilized anti-KIT MoAb, L6 (20 pg/mL), also induced vH]-thymidine incorporation into M07e cells somewhat and synergized with GM-CSF in inducing proliferation of this cell line, albeit its effect was weaker than that of YB5.B8 MoAb. Furthermore, combination of antibodies against anti-a and antip common chains of GM-CSF receptor activated M07e cell growth (unpublished data by K. Kurosawa and K. Miyazawa). The data presented here provide a possibility that orphan receptors such as TEK,27,28 and STK,2' whose cognate ligands have not yet been characterized, could be activated and their biologic effects induced ligand-independently by immobilized specific antibodies against the extracellular domain of the receptors. In addition, because several oncogenic mutants of tyrosine kinase receptors such as Fms and Neu are constitutively activated by stabilization of receptor dimers:3" it may possible to establish a system using a specific antibody directed against the receptor to activate receptor and exert biologic effects more potently than the natural ligand.
